Akebia Therapeutics, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Waltham, MA
AKBA chart
What traders are saying about $AKBA
Latest postsAkebia Therapeutics, Inc. news
- Akebia Therapeutics, Inc. (NASDAQ:AKBA) Analysts Are Cutting Their Estimates: Here's What You Need To Know
Simply Wall St ·
- Akebia Therapeutics (NASDAQ:AKBA) Stock Gets Downgrade from Wall Street Zen
MarketBeat ·
- Akebia Therapeutics, Inc. (AKBA) stock price, news, quote and history
Yahoo Finance Australia ·
- Akebia Therapeutics, Inc. (AKBA) Stock Price, News, Quote & History
Yahoo! Finance Canada ·
- Akebia Therapeutics Stock Price Forecast. Should You Buy AKBA?
StockInvest.us ·
- Akebia (AKBA) Q3 2026 Earnings Call Transcript
fool.com ·
- Akebia Therapeutics Is Maintained at Buy by HC Wainwright & Co.
Moomoo ·
- Akebia Therapeutics Insiders Lose Out As Stock Sinks To US$0.43
Moomoo ·
- Akebia Therapeutics Inc (AKBA) (Q3 2026) Earnings Call Highlights: Vafseo Demand Outpaces ...
Yahoo Finance ·
- Akebia Therapeutics (NASDAQ:AKBA) Issues Earnings Results, Misses Expectations By $0.01 EPS
MarketBeat ·
- BTIG maintains Akebia Therapeutics at Buy, lowers price target to $3 from $4
TradingView ·
- $AKBA stock is down 36% today. Here's what we see in our data.
Quiver Quantitative ·
Akebia Therapeutics, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $236.2M | $160.2M | $194.6M | $292.5M |
| Net income | -$5.3M | -$69.4M | -$51.9M | -$94.2M |
| Diluted EPS | $-0.02 | $-0.33 | $-0.28 | $-0.52 |
| Total assets (year end) | $376.6M | $220.7M | $241.7M | $356.1M |
| Cash and equivalents (year end) | $184.8M | $51.9M | $42.9M | $90.5M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Akebia Therapeutics, Inc.
- Ticker
- AKBA (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Waltham, MA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1517022
Frequently asked questions
What exchange is Akebia Therapeutics, Inc. listed on?
Akebia Therapeutics, Inc. trades on the Nasdaq under the ticker symbol AKBA.
What industry is Akebia Therapeutics, Inc. in?
Akebia Therapeutics, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Akebia Therapeutics, Inc. headquartered?
Akebia Therapeutics, Inc.'s business address on file with the SEC is in Waltham, MA.
When does Akebia Therapeutics, Inc.'s fiscal year end?
Akebia Therapeutics, Inc.'s fiscal year ends on December 31.
How much revenue did Akebia Therapeutics, Inc. report?
Akebia Therapeutics, Inc. reported $236.2M in revenue for calendar year 2025, according to its SEC filings.